Global clinical trials.
Delivered.
For life sciences companies — bringing structure, alignment, and direction to complex clinical programs.
When I am most often brought in:
- 01
When a program or company enters a new phase
A new study, a new region or a growing clinical operations function. I build the structure, teams and processes needed to turn development plans into reliable execution.
- 02
When the program carries significant weight
A highly visible study, critical milestone or decision that will shape the company's next stage. I take overall accountability for operational delivery and keep the program connected to its intended outcome.
- 03
When delivery starts to drift
Milestones move, decisions slow down and the real problem is difficult to name. I find where the issue sits, restore clarity and turn decisions into progress before the risk becomes a setback.
My experience spans the full drug development lifecycle, allowing me to look at the big picture and identify what the program truly needs to succeed.
End-to-end perspective
Preclinical research through global Phase III, in start-ups and in large pharma.
Truly global complexity
Programs running simultaneously across North America, Europe, LATAM and APAC, under regulatory and budget pressure.
Operational certainty, from start to finish
Stable development and full transparency for partners. Focus on preventing bottlenecks and keeping timelines and costs predictable.
Let's talk about your program.
Regardless of the challenge — let’s connect.